8 Coupons
-
Special Offer
-
30% off
all programs
-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
0
.
we have sent you a verification email. to verify, just follow the link in the message
.
.
.executive director of saen michael budkie made these reports public in a letter addressed to chancellor carol christ on wednesday .